Avantor Management
Management criteria checks 2/4
Avantor's CEO is Emmanuel Ligner, appointed in Aug 2025, has a tenure of less than a year. directly owns 0.013% of the company’s shares, worth $955.25K. The average tenure of the management team and the board of directors is 2.5 years and 4.3 years respectively.
Key information
Emmanuel Ligner
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.01% |
| Management average tenure | 2.5yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Avantor, Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
Nov 01
There's No Escaping Avantor, Inc.'s (NYSE:AVTR) Muted Earnings Despite A 28% Share Price Rise
Oct 28Avantor: Continued Earnings Contraction Phase
Sep 15We Think Avantor (NYSE:AVTR) Is Taking Some Risk With Its Debt
Sep 12Concerns Surrounding Avantor's (NYSE:AVTR) Performance
Aug 12What Is Avantor, Inc.'s (NYSE:AVTR) Share Price Doing?
Jun 26Earnings Working Against Avantor, Inc.'s (NYSE:AVTR) Share Price
May 14Avantor: A Healthier Diagnosis As Expectations Cool
Apr 26At US$17.28, Is Avantor, Inc. (NYSE:AVTR) Worth Looking At Closely?
Mar 11Avantor: Mundane Business, Solid Cash Flow, Potential New Risks
Mar 07Is Avantor (NYSE:AVTR) A Risky Investment?
Feb 18Avantor: Durable FCF Generator Trading For Cheap
Dec 18Avantor: Uninspiring, Even Amidst Some Green Shoots
Oct 24
New Operating Model And Bioprocessing Innovations Promise Robust Growth And Market Leadership
Implementation of a new operating model and ongoing cost transformation initiatives are streamlining execution and improving net margins through cost savings.Avantor: Yet To Evidence Economic Value For Valuation Repricing, Reiterate Hold
Aug 13CEO
Emmanuel Ligner
Mr. Emmanuel Ligner is President and Chief Executive Officer of Avantor, Inc. from August 18, 2025 and serves as its Director. He was Chief Executive Officer of Cerba HealthCare S.A.S. from March 01, 2024...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive VP & CFO | 2.5yrs | US$3.89m | 0.0014% $ 105.7k | |
| Executive VP | 2.6yrs | US$2.83m | 0.0022% $ 164.5k | |
| Executive Vice President of Bioscience Production | 2.3yrs | US$3.73m | 0.0017% $ 126.6k | |
| President | less than a year | no data | 0.013% $ 955.2k | |
| Executive VP & COO | less than a year | no data | no data | |
| Senior VP | 6.8yrs | no data | 0.0081% $ 601.6k | |
| Executive VP & Chief Information Officer | 7.8yrs | US$3.19m | no data | |
| Senior VP of Global Communications & Brand | no data | no data | no data | |
| Executive VP & Chief Human Resources Officer | 2.5yrs | no data | 0.025% $ 1.9m | |
| Executive Vice President of AMEA | 7.8yrs | no data | 0.0088% $ 653.7k | |
| President of Laboratory Solutions | 1.7yrs | no data | 0.00098% $ 73.0k | |
| Executive VP | 8.2yrs | no data | no data |
Experienced Management: AVTR's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | no data | no data | 0.013% $ 955.2k | |
| Independent Chairman of the Board | 5.8yrs | US$329.98k | 0.050% $ 3.7m | |
| Independent Director | 4.3yrs | US$329.98k | 0.0039% $ 290.4k | |
| Chair of Scientific Advisory Board | 2.4yrs | US$3.09m | no data | |
| Independent Director | 6.4yrs | US$317.48k | 0.0059% $ 435.6k | |
| Independent Director | 5.8yrs | US$324.98k | 0.0064% $ 474.3k | |
| Independent Director | 4.8yrs | US$314.98k | 0.0039% $ 291.9k | |
| Member of Scientific Advisory Board | 2.4yrs | no data | no data | |
| Independent Director | 4.3yrs | US$317.48k | 0.0027% $ 203.3k | |
| Independent Director | 4.6yrs | US$312.48k | 0.0030% $ 221.1k | |
| Member of Scientific Advisory Board | 2.4yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.4yrs | no data | no data |
Experienced Board: AVTR's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/02 08:30 |
| End of Day Share Price | 2026/02/02 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Avantor, Inc. is covered by 31 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Catherine Ramsey Schulte | Baird |
| Luke Sergott | Barclays |
| Michael Ryskin | BofA Global Research |